Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

Frontiers Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants - ScienceDirect

Viruses, Free Full-Text

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

IJMS, Free Full-Text

Viruses, Free Full-Text

Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies

Small molecules in the treatment of COVID-19

Cells, Free Full-Text

Early Research Finds Extracts from Sweet Wormwood Plant Can Inhibit the COVID-19 Virus